Charles River Laboratories (CRL)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$228.72-1.17%
Close 2026-07-07 · 1-day change
Reading CRL? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRL free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading CRL? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CRL free→QuarterlyIQ Insights · CRL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 4,027.0 | 4,015.4 | 4,050.0 | 4,129.4 | 3,976.1 | 3,540.2 | 2,923.9 | 2,621.2 | 2,266.1 | 1,857.6 | 1,363.3 | 1,363.3 | 1,297.7 | 1,165.5 | 1,129.5 | 1,133.4 | 1,133.4 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,857.6 | 1,363.3 | 1,363.3 | 1,297.7 | 1,165.5 | 1,129.5 | 1,133.4 | 1,133.4 |
| Gross Profit | — | — | — | — | — | — | — | 262.3 | 226.4 | 179.9 | 179.9 | 140.6 | 119.9 | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 724.7 | 743.1 | 751.0 | 747.9 | 665.1 | 619.9 | 528.9 | 517.6 | 443.9 | 373.4 | 300.4 | 300.4 | 269.0 | 225.7 | 208.2 | 232.5 | 232.5 |
| Operating Income | 70.4 | 25.2 | 227.3 | 617.3 | 651.0 | 589.9 | 432.7 | 351.2 | 331.4 | 287.5 | 206.4 | 206.4 | 177.7 | 151.4 | 165.8 | (298.5) | (298.5) |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | — | 136.7 | 59.3 | 73.9 | 86.4 | 60.9 | 63.8 | 29.8 | 15.1 | 15.1 | 12.0 | 21.0 | 33.3 | 35.3 | 35.3 |
| Interest & Investment Income | 4.6 | 4.9 | 8.6 | 5.2 | 0.8 | 0.7 | 0.8 | 1.5 | 0.8 | 0.7 | 1.0 | 1.0 | — | 0.7 | 0.6 | 1.2 | 1.2 |
| Net Interest Expenses | — | — | — | 131.5 | 58.5 | 73.3 | 85.6 | 59.4 | 63.0 | 29.1 | 14.0 | 14.0 | — | 20.2 | 32.8 | 34.1 | 34.1 |
| Asset Writedown | — | — | — | — | — | — | — | 0.0 | 0.0 | 17.2 | — | — | 2.2 | 4.2 | 3.5 | 91.4 | 91.4 |
| EBT, Incl. Unusual Items | — | (99.5) | 93.1 | 581.3 | 623.0 | 480.7 | 447.1 | 304.1 | 281.7 | 297.0 | 195.4 | 195.4 | 177.6 | 138.3 | 129.7 | (334.1) | (334.1) |
| Income Tax Expense | 17.4 | 42.7 | 67.8 | 100.9 | 130.4 | 81.9 | 81.8 | 50.0 | 54.5 | 171.4 | 43.4 | 43.4 | 47.7 | 32.9 | 27.6 | 0.0 | 0.0 |
| Earnings from Continuing Operations | — | — | — | — | — | — | 365.3 | 254.1 | 227.2 | 125.6 | 152.0 | 152.0 | 129.9 | 105.4 | 102.1 | (334.1) | (334.1) |
| Net Income | |||||||||||||||||
| Minority Interest | 1.8 | 2.2 | 3.1 | 5.7 | 6.4 | 7.9 | 1.0 | 2.0 | 2.4 | 2.1 | 1.8 | 1.8 | — | 1.3 | 0.6 | (5.4) | (5.4) |
| Net Income | (184.7) | (144.3) | 22.2 | 474.6 | 486.2 | 391.0 | 364.3 | 252.0 | 226.4 | 123.4 | 149.3 | 149.3 | — | — | — | — | (336.7) |
| Per Share | |||||||||||||||||
| Basic EPS | (3.77) | (2.91) | 0.20 | 9.27 | 9.57 | 7.77 | 7.35 | 5.17 | 4.72 | 2.60 | 3.21 | 3.21 | 2.72 | 2.15 | 2.03 | (5.38) | (5.38) |
| Diluted EPS | (3.77) | (2.91) | 0.20 | 9.22 | 9.48 | 7.60 | 7.20 | 5.07 | 4.62 | 2.54 | 3.13 | 3.13 | 2.66 | 2.12 | 2.01 | (5.38) | (5.38) |
| Revenue per Share | 82.27 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 49.0 | 49.6 | 51.4 | 51.2 | 50.8 | 50.3 | 49.6 | 48.7 | 47.9 | 47.5 | 46.5 | 46.5 | 46.6 | 47.7 | 47.9 | 62.6 | — |
| Diluted Weighted Avg Shares | 49.0 | 49.6 | 51.6 | 51.5 | 51.3 | 51.4 | 50.6 | 49.7 | 49.0 | 48.6 | 47.6 | — | — | 48.5 | 48.4 | 62.6 | — |
| Supplemental | |||||||||||||||||
| EBITDA | — | 428.5 | 589.1 | 931.4 | 954.8 | 855.4 | 667.7 | 549.2 | 493.2 | 418.7 | 301.3 | 301.3 | 274.1 | 248.0 | 247.0 | (204.9) | (204.9) |
| EBIT | 70.4 | 25.2 | 227.3 | 617.3 | 651.0 | 589.9 | 432.7 | 351.2 | 331.4 | 287.5 | 206.4 | 206.4 | 177.7 | 151.4 | 165.8 | (298.5) | (298.5) |
| Effective Tax Rate | — | -42.9% | 72.8% | 17.4% | 20.9% | 17.0% | 18.3% | 16.5% | 19.3% | 57.7% | 22.2% | 22.2% | 26.8% | 23.8% | 21.3% | -0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.